UWPG
ABBV icon

Ullmann Wealth Partners Group’s AbbVie ABBV Stock Holding History

Ullmann Wealth Partners Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
6,419
+200
+3% +$43K 0.15% 63
2026
Q1 		$1.35M Sell
6,219
-449
-7% -$99.6K 0.14% 67
2025
Q4 		$1.45M Buy
6,668
+21
+0.3% +$4.78K 0.15% 62
2025
Q3 		$1.54M Buy
6,647
+224
+3% +$45.6K 0.17% 57
2025
Q2 		$1.19M Buy
6,423
+61
+1% +$11.3K 0.14% 61
2025
Q1 		$1.33M Buy
6,362
+167
+3% +$32.5K 0.18% 52
2024
Q4 		$1.1M Sell
6,195
-131
-2% -$24.1K 0.14% 57
2024
Q3 		$1.25M Buy
6,326
+3,301
+109% +$616K 0.16% 49
2024
Q2 		$519K Buy
3,025
+311
+11% +$51.5K 0.07% 73
2024
Q1 		$494K Buy
2,714
+447
+20% +$77K 0.07% 72
2023
Q4 		$351K Buy
2,267
+37
+2% +$5.39K 0.06% 82
2023
Q3 		$332K Buy
2,230
+175
+9% +$25.7K 0.06% 77
2023
Q2 		$277K Buy
2,055
+760
+59% +$111K 0.06% 85
2023
Q1 		$206K Buy
+1,295
New +$198K 0.05% 89
2017
Q3 		– Sell
-413
Closed -$29K – 50
2017
Q2 		$29K Sell
413
-43
-9% -$2.89K 0.02% 104
2017
Q1 		$29K Buy
+456
New +$28.7K 0.02% 97

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ullmann Wealth Partners Group's ABBV Position: Q2 2026 in Review

Ullmann Wealth Partners Group increased its AbbVie (ABBV) stake by 3.2% in Q2 2026, buying an estimated $43K and bringing the position to 6,419 shares worth $1.62M. The position accounts for 0.15% of the portfolio, ranked #63.

Ullmann Wealth Partners Group first reported a position in ABBV in Q1 2017 and has held it in 16 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ullmann Wealth Partners Group held 6,419 shares of AbbVie worth $1.62M as of Q2 2026.
  • Ullmann Wealth Partners Group bought 200 AbbVie shares in Q2 2026, an estimated $43K.
  • AbbVie made up 0.15% of Ullmann Wealth Partners Group's portfolio in Q2 2026, its #63 holding.
  • Ullmann Wealth Partners Group first reported a position in AbbVie in Q1 2017 and has held it in 16 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ullmann Wealth Partners Group's 13F filing for Q2 2026, filed 10 Aug 2026.